A carregar...

Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker

BACKGROUND: Many putative disease blood biomarkers discovered in genomic and proteomic studies await validation in large clinically annotated cohorts of patient samples. ELISA assays require large quantities of precious blood samples and are not high-throughput. The reverse phase protein microarray...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aguilar-Mahecha, Adriana, Cantin, Christiane, O'Connor-McCourt, Maureen, Nantel, Andre, Basik, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2672067/
https://ncbi.nlm.nih.gov/pubmed/19348683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-5956-7-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!